XML 26 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 79 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Cash Flows From Operating Activities:      
Net loss $ (17,581,092) $ (8,258,789) $ (87,190,110)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 988 988 8,138
Loss on disposal of property and equipment 2,321   2,321
Stock-based compensation expense 792,298 296,558 3,760,947
Accretion of discount/premium on investment securities (160,576)   (160,576)
Purchased in-process research and development     28,156,502
Change in fair value of derivative instruments-warrants 1,309,401 1,036,375 (4,244,414)
Changes in operating assets and liabilities:      
Security deposit (5,486)   (19,511)
Accounts payable and accrued expenses 2,172,563 (191,634) 4,196,519
Prepaid expenses and other current assets (345,317) 136,185 (1,408,719)
Total Adjustments 3,766,192 1,278,472 30,291,207
Net Cash Used in Operating Activities (13,814,900) (6,980,317) (56,898,903)
Cash Flows From Investing Activities:      
Net cash paid on Exchange Transaction     (155,326)
Repayment from/(loans to) related parties (395,153) 295,614 (1,936,609)
Purchases of available-for-sale securities (20,000,000)   (20,000,000)
Additions to property and equipment     (12,195)
Net Cash (Used in)/Provided by Investing Activities (20,395,153) 295,614 (22,104,130)
Cash Flows From Financing Activities:      
Capital contribution by shareholders     8,893
Issuance of common stock     2,000
Proceeds from sale of common stock 51,750,000 5,461,242 112,293,164
Proceeds from exercise of warrants   415,309 415,309
Proceeds from sale of unregistered common stock to founders     18,100
Fees and expenses related to sale of common stock (3,357,930) (395,620) (6,307,533)
Net Cash Provided by Financing Activities 48,392,070 5,480,931 106,429,933
Net increase (decrease) in cash and cash equivalents 14,182,017 (1,203,772) 27,426,900
Cash and cash equivalents at beginning of period 13,244,883 1,707,516  
Cash and cash equivalents at end of period 27,426,900 503,744 27,426,900
Supplementary disclosure of cash flow information:      
Cash paid for taxes 11,948 8,021 83,564
Value of warrants classified as derivative liability - net 169,203 3,920,500 9,048,132
Value of common stock issued to induce stockholders to extend lock-up agreements     $ 3,235,040